Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastro-enteropancreatic neuroendocrine tumor × regorafenib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan Syndrome 6 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Insulinoma 1 Glucagonoma 1

Interventions

lutetium Lu 177 dotatate 2 pasireotide 1 folfirinox 1 copper dotatate CU-64 1 arginyllysine 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Octreotide 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Cytokines 1 Cryotherapy 1 Carboplatin 1 Acupuncture Therapy 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡